BETA

IPO registrations (S-1, F-1) · Registrants

NOVADEL PHARMA INC

SEC CIK
1043873 · filings on EDGAR ↗
Former names
FLEMINGTON PHARMACEUTICAL CORP (1997–2002)
Registration
Form S-1, first filed 2010-06-09, last 2011-04-04; 2 initial registrations, 7 amendments
Outcome
Final prospectus filed 2011-02-15; declared effective 2010-06-29
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
1200 ROUTE 22 EAST, SUITE 2000, Bridgewater, NJ 08807
EIN
22-2407152
EDGAR entity type
operating
Insiders and CEO pay
NOVADEL PHARMA INC on the corporate pages

Offering terms

Final price
$0.17 per share (424B4 filed 2011-02-15)
Shares sold
1,667
Gross proceeds
$275 before underwriting discounts and any over-allotment option
Listing
under the symbol NVDL.OB
Lead underwriters
Roth Capital Partners

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 14

FiledFormWhat it isName as filedEDGAR
2010-06-09S-1S-1 (registration)NOVADEL PHARMA INC0000930413-10-003385 ↗
2010-06-22S-1/AS-1/A (amendment)NOVADEL PHARMA INC0001043873-10-000027 ↗
2010-06-29EFFECTEFFECT (declared effective)NOVADEL PHARMA INC9999999995-10-001987 ↗
2010-10-21S-1S-1 (registration)NOVADEL PHARMA INC0000930413-10-005172 ↗
2010-11-05S-1/AS-1/A (amendment)NOVADEL PHARMA INC0000930413-10-005465 ↗
2011-01-14S-1/AS-1/A (amendment)NOVADEL PHARMA INC0000930413-11-000243 ↗
2011-02-04S-1/AS-1/A (amendment)NOVADEL PHARMA INC0000930413-11-000744 ↗
2011-02-10S-1/AS-1/A (amendment)NOVADEL PHARMA INC0000930413-11-000879 ↗
2011-02-14EFFECTEFFECT (declared effective)NOVADEL PHARMA INC9999999995-11-000449 ↗
2011-02-15424B4424B4 (final prospectus)NOVADEL PHARMA INC0000930413-11-001078 ↗
2011-04-04S-1/AS-1/A (amendment)NOVADEL PHARMA INC0001043873-11-000017 ↗
2011-04-04S-1/AS-1/A (amendment)NOVADEL PHARMA INC0001043873-11-000019 ↗
2011-04-12EFFECTEFFECT (declared effective)NOVADEL PHARMA INC9999999995-11-000986 ↗
2011-06-07EFFECTEFFECT (declared effective)NOVADEL PHARMA INC9999999995-11-001756 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2011-02-10S-1/Aregistration statement$0.1740,000,000$6,600,000 NVDL.OB1primary document; price sentence, shares headline, proceeds computed, cover names 1document ↗
2011-02-15424B4final prospectus$0.171,667$275 NVDL.OB1primary document; price sentence, shares headline, proceeds computed, cover names 1document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
SPICER MICHAEL E BOfficerCFO and Corporate Secretary; CFO and Secretary; Chief Financial Officer72006–2009
Bonney Thomas EDirector112006–2011
HAMILTON WILLIAM F PHDDirector42006–2008
Nemeroff CharlesDirector102006–2011
RATOFF STEVEN BDirector; Director,OfficerChief Executive Officer; President and CEO172006–2010
ROSENWALD LINDSAY A MDTenPercentOwner42006–2007
Moorin JayTenPercentOwner102006–2012
ProQuest Associates III LLCTenPercentOwner102006–2012
ProQuest Investments III, L.P.Director,TenPercentOwner; TenPercentOwner102006–2012
SCHREIBER ALAINTenPercentOwner102006–2012
CAISSE DE DEPOT ET PLACEMENT DU QUEBECTenPercentOwner22006
LOBELL J JAYDirector32006–2008
Bergstrom David HOfficerChief Operating Officer; SVP & Chief Operating Officer; SVP-Chief Operating Officer62006–2009
Egberts Jan HDirector,OfficerPresident and CEO12007
Baric Mark JDirector82007–2011
ZODDA DENI M PHDOfficerSVP and Chief Business Officer; SVP, Chief Business Officer42007–2009
PROQUEST ASSOCIATES II LLCTenPercentOwner72008–2012
PROQUEST INVESTMENTS II LPTenPercentOwner72008–2012
PROQUEST INVESTMENTS II ADVISORS FUND LPTenPercentOwner62009–2012
Warusz Joseph MichaelOfficerPrincipal Accounting Officer12009
Johnson Craig AOfficerSr. VP, CFO and Secretary22010

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationNOVADEL PHARMA INC.NJState business registriesEIN (EXACT, as the state registration reports it)
Patent assigneeNovadel Pharma Inc.NJPatents (USPTO)name and state
SEC filerNOVADEL PHARMA INCSEC filers (EDGAR)CIK (EXACT)
Trademark ownerNovaDel Pharma Inc.NJTrademarks (USPTO)name and state
Form 5500 plan sponsorNOVADEL PHARMA INC.EIN (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, NJ first:

More with this interest.

In other datasets, the same topic (Health) in NJ:

Interests: Pharmaceutical Preparations · Health